Table 1 Shows clinicopathological characteristics of GBC patients
From: Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma
Variables | n = 176 |
|---|---|
Age in years median (Range) | 55 (17–80) |
Gender, n (%) | Male: 38 (21.6%) Female: 138 (78.4%) |
Serum CEA, ng/ml median (Range) | 4.2 (0.5–304.2) |
Serum CA19–9, IU/ml median (Range) | 28.2 (0.6–38,689) |
Disease status, n (%) | Resectable: 92 (52.3%) |
Unresectable: 17 (9.6%) | |
Metastatic: 67 (38%) | |
AJCC staging, n (%) | Stage 1: 16 (9.1%) |
Stage 2: 25 (14.2%) | |
Stage 3: 43 (24.4%) | |
Stage 4A: 17 (9.7%) | |
Stage 4B: 75 (42..6%) |